Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-inferiority study of metronidazole 0.75% cream (Rosiced) vs Rozex in papulopustular rosacea
2006-007029-29Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metronidazole in papulopustular rosacea and rosacea (3 arms), sponsored by Pierre Fabre Laboratories. Primary endpoints: Change in inflammatory lesion count at week 12 and Change in inflammatory lesion count at week 6. Started Mar 2007; status: completed.
02
Drugs
metronidazole
03
Conditions
papulopustular rosacearosacea
Beyond the preview
Go deeper on 2006-007029-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-007029-29.